What percentage of patients on dabigatran, rivaroxaban, and clopidogrel have increased APTT and PT?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18382372
Cited by: 0

Abstract

Dabigatran and rivaroxaban alter APTT and PT to varying extents, whereas clopidogrel usually does not affect these parameters.

Fields of Study & Subjects

Atrial Fibrillation Management and Outcomes Blood Coagulation and Thrombosis Mechanisms Antiplatelet Therapy and Cardiovascular Diseases

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
27 January 2026